BlackRock ECAT insider Saba Capital sells 56,976 shares at $16
Saba Capital Management, L.P., a director and 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares.
Rhea-AI Filing Summary
Saba Capital Management, L.P., a director and 10% owner of BlackRock ESG Capital Allocation Term Trust (ECAT), reported a sale of common shares. On 11/26/2025, the reporting person sold 56,976 shares of ECAT common stock at a price of $16 per share, marked with transaction code "S" for a sale. Following this transaction, the reporting person reported 26,735,799 shares of ECAT common stock beneficially owned with indirect ownership.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 56,976 | $16.00 | $912K |
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What transaction did Saba Capital report in ECAT common stock?
Saba Capital Management, L.P. reported a sale of 56,976 shares of BlackRock ESG Capital Allocation Term Trust (ECAT) common stock on 11/26/2025 at $16 per share, coded as a sale ("S").
What is the relationship of the reporting person to BlackRock ESG Capital Allocation Term Trust (ECAT)?
The reporting person is identified as both a Director and a 10% Owner of BlackRock ESG Capital Allocation Term Trust (ECAT).
Is the ECAT position held directly or indirectly by the reporting person?
The 26,735,799 ECAT shares reported after the transaction are held with indirect ownership form, as indicated in the filing.
On what date was the earliest transaction reported for this ECAT Form 4?
The earliest transaction date reported for this Form 4 relating to ECAT is 11/26/2025.
Who signed the Form 4 for the ECAT transaction?
The Form 4 relating to ECAT was signed by Saba Capital Management, L.P. by Zachary Gindes and by Boaz Weinstein, each with a signature date of 12/01/2025.
AI-generated analysis. How Rhea-AI works. Not financial advice.